Newsletter | June 3, 2025

06.03.25 -- Designing The Next Wave Of T Cell Engagers

FEATURED EDITORIAL

Designing The Next Wave Of T Cell Engagers

Abpro's associate director of biology has led programs in immuno-oncology R&D with a focus on therapeutic T cell engagers. We caught up with him to discuss how industry can pave a future for the field.

INDUSTRY INSIGHTS

A Hybrid Modeling Approach To Accelerate Media And Feed Development

Explore the outcomes of a study focusing on building a mechanistic model to determine the growth kinetics of a CHO-based process producing a mAb.

Genome Editing of Human Primary T Cells With Lipid Nanoparticles

We show CRISPR/Cas9-mediated knockouts of the T cell receptor and explore multi-step LNP engineering to produce TCRÉ‘Β KO CAR T cells.

Optimized Stability Storage

A healthcare manufacturer facing space constraints and regulatory pressures outsourced their stability storage needs to another company, resulting in reduced costs and focus on core competencies.

Diagnose Absorption Risks To Improve Preclinical And Clinical Outcomes

Physiologically based pharmacokinetic modeling is a powerful tool for clinical trial design that can be leveraged alongside early development experiments to reduce costs and accelerate timelines.

Continuous Manufacturing: An Evolving Technology For Drug Manufacturing

Explore the exciting developments in continuous manufacturing and learn how leveraging this innovative technology can help improve manufacturing processes and discover new clinical candidates.

Spray Drying For Innovative Dry Powder Inhaler Combination Formulations

Combination therapies delivered directly to the lung by dry powder inhalants are an effective means of reducing patient burden. Read about case studies that illustrate the potential for improving care.

MOST POPULAR NEWS

Nuclera & Cytiva Collaborate To Accelerate Characterization Of Proteins

Radyus Research & Eurofins CDMO Alphora Announce Strategic Partnership

GATC Health Paper Quantifies AI-Driven Capital Efficiencies

Selvita Acquires License For MDC's Patented Target Engagement Technology

Avenzo Therapeutics Announces FDA Clearance Of IND Application For AVZO-1418

HCVC Leads kyron.bio €5.5M Round To Use Glycan Engineering For Advanced Drug Design

Charles River & CHDI Foundation Extend Collaboration On Huntington's Disease Research

Siegfried Expands Production Capacity For Ophthalmic Drugs In El Masnou

GSK's Depemokimab Accepted For Review By Health Canada

Eton Pharmaceuticals Announces U.S. FDA Approval For KHINDIVI (Hydrocortisone) Oral Solution

Global Summit On MPS Research Set To Shape The Future Of Drug Development & Disease Modeling

SOLUTIONS

PBPK Predictive Modeling Services

Pharmaceutical Labeling And Kitting Services